Search Results - "Cao, Yingming"

Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study by Guo, Jiajia, Yang, Houpu, Wang, Shu, Cao, Yingming, Liu, Miao, Xie, Fei, Liu, Peng, Zhou, Bo, Tong, Fuzhong, Cheng, Lin, Liu, Hongjun, Wang, Siyuan

“…Recent studies show that near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) has the potential to improve the performance of sentinel lymph…”
Get full text

Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer by Wang, Chaobin, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Liu, Hongjun, Cheng, Lin, Liu, Miao, Guo, Jiajia, Xie, Fei, Yang, Houpu, Wang, Siyuan, Peng, Yuan, Wang, Shu

“…Purpose This study aimed to assess the efficacy of the combination of indocyanine green (ICG) and methylene blue (MB) dye in early breast cancer patients…”
Get full text

Neoadjuvant docetaxel and capecitabine (TX) versus docetaxel and epirubicin (TE) for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial by Yang, Houpu, Xu, Ling, Guan, Shan, Hao, Xiaopeng, Ge, Zhicheng, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Cheng, Lin, Liu, Miao, Liu, Hongjun, Xie, Fei, Wang, Siyuan, Peng, Yuan, Wang, Chaobin, Wang, Shu

“…The combination of taxanes and anthracyclines is still the mainstay of chemotherapy for early breast cancer. Capecitabine is an active drug with a favorable…”
Get full text

Application of the ACOSOG Z0011 criteria to Chinese patients with breast cancer: a prospective study by Peng, Yuan, Liu, Miao, Li, Xianan, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Liu, Hongjun, Cheng, Lin, Guo, Jiajia, Xie, Fei, Yang, Houpu, Wang, Siyuan, Wang, Chaobin, Chen, Yalin, Wang, Shu

“…Although the ACOSOG Z0011 study showed that axillary lymph node dissection (ALND) could be avoided in a specific population of sentinel lymph node-positive…”
Get full text

Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer by Houpu, Yang, Fei, Xie, Yang, Yang, Fuzhong, Tong, Peng, Liu, Bo, Zhou, Lin, Cheng, Yingming, Cao, Miao, Liu, Hongjun, Liu, Siyuan, Wang, Yuan, Peng, Danhua, Shen, Shu, Wang

“…Background We implemented selective use of frozen section (FS) to optimize accuracy and cost control in the intraoperative diagnosis of sentinel lymph node…”
Get full text

Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients by Peng, Yuan, Hu, Taobo, Cheng, Lin, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Liu, Miao, Liu, Hongjun, Guo, Jiajia, Xie, Fei, Yang, Houpu, Wang, Siyuan, Wang, Chaobin, Wang, Shu

“…The dilemma of undertreatment and overtreatment of elderly breast cancer patients is common. This study aimed to investigate clinicopathological features,…”
Get full text

Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer by Wang, Shu, Yang, Houpu, Tong, Fuzhong, Zhang, Jiaqing, Yang, Deqi, Liu, Hongjun, Cao, Yingming, Liu, Peng, Zhou, Po, Cheng, Lin, Liu, Miao, Guo, Jiajia

“…Triple negative breast cancer(TNBC)is characterized by estrogen receptor (ER) negative, progesterone receptor (PgR)negative and human epidermal growth factor…”
Get more information

Clinicopathological Features, Treatment and Prognosis of Invasive Breast Cancer Patients over 70 Years Old by Peng, Yuan, Cheng, Lin, Wang, Shu, Tong, Fuzhong, Liu, Peng, Cao, Yingming, Zhou, Bo, Liu, Hongjun, Liu, Miao, Guo, Jiajia, Xie, Fei, Yang, Houpu, Wang, Siyuan

“…Objective To investigate the clinicopathological characteristics, treatment patterns and prognosis factors of female invasive breast cancer patients over 70…”
Get full text

Protein profiling predicts the response to anthracycline and taxanes based neo-adjuvant chemotherapy in breast cancer by Wang, Shu, Yang, Houpu, Guo, Jiajia, Liu, Miao, Tong, Fuzhong, Cao, Yingming, Zhou, Bo, Liu, Peng, Liu, Hongjun, Cheng, Lin, Xie, Fei, Yang, Deqi, Zhang, Jiaqing

“…Neo-adjuvant chemotherapy for breast cancer substantially benefits patients who achieve pathological response. However, clinical or pathological response…”
Get full text

Use of high‐resolution full‐field optical coherence tomography and dynamic cell imaging for rapid intraoperative diagnosis during breast cancer surgery by Yang, Houpu, Zhang, Shuwei, Liu, Peng, Cheng, Lin, Tong, Fuzhong, Liu, Hongjun, Wang, Siyuan, Liu, Miao, Wang, Chaobin, Peng, Yuan, Xie, Fei, Zhou, Bo, Cao, Yingming, Guo, Jiajia, Zhang, Yuanyuan, Ma, Yingteng, Shen, Danhua, Xi, Peng, Wang, Shu

“…Background Although traditional intraoperative assessments (ie, frozen sections) may lower reoperation rates in patients with breast cancer, time/tissue…”
Get full text

Lymph Node Predictive Model with in Vitro Ultrasound Features for Breast Cancer Lymph Node Metastasis by Han, Pu, Yang, Houpu, Liu, Miao, Cheng, Lin, Wang, Siyuan, Tong, Fuzhong, Liu, Peng, Zhou, Bo, Cao, Yingming, Liu, Hongjun, Wang, Chaobin, Peng, Yuan, Shen, Danhua, Wang, Shu

“…Ultrasound diagnosis of axillary lymph nodes has the advantages of ease, convenience and low cost; however, most previous studies evaluated lymph node…”
Get full text

Neoadjuvant docetaxel and capecitabine for locally advanced or early her2-negative breast cancer: an open-label, randomized, multi-center, phase II Trial by Yang, Houpu, Xu, Ling, Guan, Shan, Hao, Xiaopeng, Ge, Zhicheng, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Cheng, Lin, Liu, Miao, Liu, Hongjun, Xie, Fei, Wang, Siyuan, Peng, Yuan, Wang, Chaobin, Wang, Shu

“…The combination of taxanes and anthracyclines is still the mainstay of chemotherapy for early breast cancer. Capecitabine is an active drug with a favorable…”
Get full text

The efficacy and efficiency of half frozen section assessment of breast cancer sentinel lymph nodes: A retrospective analysis of 1116 cases by Yang, Houpu, Wang, Shu, Guo, Jiajia, Cao, Yingming

“…Abstract only…”
Get full text

Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients? by Yang, Houpu, Zhou, Lixin, Wang, Shu, Cao, Yingming, Tong, Fuzhong, Liu, Peng, Zhou, Bo, Cheng, Lin, Liu, Miao, Liu, Hongjun, Xie, Fei, Guo, Jiajia, Wang, Siyuan, Peng, Yuan

“…Different biological subtype breast cancers respond differently to neoadjuvant chemotherapy, but it is unknown whether neoadjuvant or adjuvant chemotherapy…”
Get full text

Clinical evaluation of effects from neoadjuvant chemotherapy with epirubicin plus paclitaxel in cases of locally advanced breast cancer--comparative study of treatment with 2 and 4 cycles by Tong, Fuzhong, Yang, Deqi, Zhou, Bo, Cao, Yingming, Liu, Peng, Liu, Hongjun, Wang, Shu, Qiao, Xinmin, Zhang, Jiaqing

“…Neoadjuvant chemotherapy of epirubicin plus paclitaxel was administered to 75 patients (including a 2-cycle group of 39 patients and a 4-cycle group of 36…”
Get more information

Combined use of indocyanine green fluorescence and methylene blue dye versus methylene blue dye alone for sentinel lymph node biopsy in breast cancer patients by Wang, Shu, Guo, Jiajia, Yang, Deqi, Cao, Yingming, Tong, Fuzhong, Zhou, Bo, Liu, Peng, Liu, Hongjun, Cheng, Lin, Liu, Miao, Yang, Houpu, Xie, Fei, Wang, Siyuan

“…Abstract only e12006 Background: Methylene blue (MB) dye is widely used in China for sentinel lymph node biopsy (SLNB). Recently indocyanine green (ICG) was…”
Get full text

Neoadjuvant versus adjuvant chemotherapy with taxanes and anthracycline-based regimen: Which leads to better outcome in patients with different subtype breast cancer? by Yang, Houpu, Wang, Shu, Zhou, Lixin, Guo, Jiajia, Cao, Yingming, Zhou, Bo, Cheng, Lin, Xie, Fei, Liu, Hongjun, Tong, Fuzhong, Liu, Miao, Liu, Peng, Wang, Siyuan, Yang, Deqi, Zhang, Jiaqing

“…Abstract only 1084 Background: Neoadjuvant chemotherapy was reported to lead to equal outcome with adjuvant therapy in operable breast cancer. However,…”
Get full text

Clinical evaluation of effects from neo-adjuvant chemotherapy with epirubicin plus paclitaxel in cases of locally advanced breast cancer by Tong, Fuzhong, Zhou, Bo, Yang, Deqi, Cao, Yingming, Liu, Peng, Liu, Hongjun, Qiao, Xinmin, Zhang, Jiaqing

“…Neo-adjuvant chemotherapy of epirubicin plus paclitaxel was administered to 23 patients with locally advanced breast cancer (including 13 cases of stage IIb, 6…”
Get more information

Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer by Yang, Deqi, Tong, Fuzhong, Cao, Yingming, Liu, Peng, Zhou, Bo, Liu, Hongjun, Qiao, Xinmin, Zhang, Jiaqing

“…To compare the efficacy and toxicity of two different regimens as neoadjuvant chemotherapy for breast cancer. Forty-eight patients with stage II, III breast…”
Get more information